# EDGAR Filing Document

**Accession Number:** 0001408970
**File Stem:** 0000940400-26-007288
**Filing Date:** 2026-2
**Character Count:** 12580
**Document Hash:** 3905df0e6d97d09371f7801cfc810310
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000940400-26-007288.hdr.sgml**: 20260223

**ACCESSION NUMBER**: 0000940400-26-007288

**CONFORMED SUBMISSION TYPE**: NPORT-P

**PUBLIC DOCUMENT COUNT**: 1

**CONFORMED PERIOD OF REPORT**: 20251231

**FILED AS OF DATE**: 20260223

**DATE AS OF CHANGE**: 20260223

**PERIOD START**: 20260630

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** AdvisorShares Trust
- **CENTRAL INDEX KEY:** 0001408970

**ORGANIZATION NAME:**
- **EIN:** 260636087
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 0630

**FILING VALUES:**
- **FORM TYPE:** NPORT-P
- **SEC ACT:** 1940 Act
- **SEC FILE NUMBER:** 811-22110
- **FILM NUMBER:** 26664886

**BUSINESS ADDRESS:**
- **STREET 1:** 4800 MONTGOMERY LANE
- **STREET 2:** SUITE 150
- **CITY:** BETHESDA
- **STATE:** MD
- **ZIP:** 20814
- **BUSINESS PHONE:** (877) 843-3831

**MAIL ADDRESS:**
- **STREET 1:** 4800 MONTGOMERY LANE
- **STREET 2:** SUITE 150
- **CITY:** BETHESDA
- **STATE:** MD
- **ZIP:** 20814

## Series and Classes Contracts Data

### AdvisorShares Psychedelics ETF (Series ID: S000072085)

| Class ID   | Class Name                     | Ticker Symbol   |
|:---|:---|:---|
| C000227806 | AdvisorShares Psychedelics ETF | PSIL            |

## Form NPORT-P: Monthly Portfolio Investments Report

### NPORT-P: Part A: General Information

**Item A.1. Information about the Registrant.**

- **a. Name of Registrant:** AdvisorShares Trust

- **b. Investment Company Act file number:** 811-22110

- **c. CIK number of Registrant:** 0001408970

- **d. LEI of Registrant:** 549300K5KGUMX2I7WM68

- **e. Address and telephone number of Registrant.**

  - **Street Address 1:** 4800 Montgomery Lane

  - **City:** Bethesda

  - **State:** MD

  - **Foreign country:** US

  - **Zip / Postal Code:** 20814

  - **Telephone number:** 877-843-3831

**Item A.2. Information about the Series.**

- **a. Name of Series:** AdvisorShares Psychedelics ETF

- **b. EDGAR series identifier (if any):** S000072085

- **c. LEI of Series:** 5493006JP686ZK0LV692

**Item A.3. Reporting period.**

- **a. Date of fiscal year-end:** 2026-06-30

- **b. Date as of which information is reported:** 2025-12-31

**Item A.4. Final filing**

Does the Fund anticipate that this will be its final filing on Form N-PORT? **No**

### Fund Information

**Total Assets:** $21794394.05

**Total Liabilities:** $3316187.07

**Net Assets:** $18478206.98

**Cash Not Reported:** $2743.86

**Monthly Return Information**

| Class               | Month 1 Return (%)   | Month 2 Return (%)   | Month 3 Return (%)   |
|:---|:---|:---|:---|
| Class ID C000227806 | 5.53%                | -4.16%               | -1.11%               |

**Monthly Gains & Losses**

| Period   | Net Realized Gain/Loss   | Net Unrealized Appreciation/Depreciation   |
|:---|:---|:---|
| Month 1  | $-717590.97              | $1704728.72                                |
| Month 2  | $247120.82               | $-1074358.20                               |
| Month 3  | $689892.95               | $-892404.32                                |

### Schedule of Portfolio Investments

| Name                         | Title                        | Identifiers                                   | Payoff Profile   | Asset Category   | Issuer Category   | Country   |   Balance | Units   | Value (USD)   | % of Net Assets   | Maturity Date   | Coupon Type   | Annualized Rate (%)   | Restricted?   |   Fair Value Level | Lending Status   |
|:---|:---|:---|:---|:---|:---|:---|---:|:---|:---|:---|:---|:---|:---|:---|---:|:---|
| GH Research PLC              | GH Research PLC              | CUSIP: 000000000<br>LEI: 875500HKJS7QQG6EWH62 | Long             | EC               | CORP              | IE        |     67112 | NS      | $852322.40    | 4.61%             |  |  |  | No            |                  1 | On Loan: —       |
| Numinus Wellness Inc         | Numinus Wellness Inc         | CUSIP: 67054W103<br>LEI: 894500HQ7NI16XOI3241 | Long             | EC               | CORP              | CA        |   4839107 | NS      | $145173.21    | 0.79%             |  |  |  | No            |                  1 | On Loan: No      |
| NRX Therapeutics Inc         | NRX Therapeutics Inc         | CUSIP: 629444209<br>LEI: 5493003FN4CLS0670T77 | Long             | EC               | CORP              | US        |    328004 | NS      | $888890.84    | 4.81%             |  |  |  | No            |                  1 | On Loan: —       |
| Silo Pharma Inc              | Silo Pharma Inc              | CUSIP: 82711P201<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    599507 | NS      | $203832.38    | 1.10%             |  |  |  | No            |                  1 | On Loan: No      |
| Enveric Biosciences Inc      | Enveric Biosciences Inc      | CUSIP: 29405E505<br>LEI: 549300CATCWKUQ6G5854 | Long             | EC               | CORP              | US        |     16974 | NS      | $61615.62     | 0.33%             |  |  |  | No            |                  1 | On Loan: —       |
| Alto Neuroscience Inc        | Alto Neuroscience Inc        | CUSIP: 02157Q109<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     44077 | NS      | $784570.60    | 4.25%             |  |  |  | No            |                  1 | On Loan: No      |
| Quantum BioPharma Ltd        | Quantum BioPharma Ltd        | CUSIP: 74764Y205<br>LEI: 529900Z3CEEEN7U9B668 | Long             | EC               | CORP              | CA        |     49633 | NS      | $362320.90    | 1.96%             |  |  |  | No            |                  1 | On Loan: —       |
| Clearmind Medicine Inc       | Clearmind Medicine Inc       | CUSIP: 185053501<br>LEI: 8945006FVE3FLKX9BN50 | Long             | EC               | CORP              | CA        |      6632 | NS      | $12003.92     | 0.06%             |  |  |  | No            |                  1 | On Loan: No      |
| Compass Pathways Plc         | Compass Pathways Plc         | CUSIP: 20451W101<br>LEI: 213800N7CUZIC6QSTZ31 | Long             | EC               | CORP              | GB        |    230910 | NS      | $1593279.00   | 8.62%             |  |  |  | No            |                  1 | On Loan: —       |
| Johnson & Johnson            | Johnson & Johnson            | CUSIP: 478160104<br>LEI: 549300G0CFPGEF6X2043 | Long             | EC               | CORP              | US        |      3056 | NS      | $632439.20    | 3.42%             |  |  |  | No            |                  1 | On Loan: No      |
| Mind Medicine MindMed Inc    | Mind Medicine MindMed Inc    | CUSIP: 60255C885<br>LEI: 549300QY8KN1O6RPFJ13 | Long             | EC               | CORP              | US        |    102838 | NS      | $1377000.82   | 7.45%             |  |  |  | No            |                  1 | On Loan: No      |
| DREY INST PREF GOV MM-M      | DREY INST PREF GOV MM-M      | CUSIP: 000000000<br>LEI: N/A                  | Long             | STIV             | RF                | US        |   3283430 | NS      | $3283429.70   | 17.77%            |  |  |  | No            |                  2 | On Loan: No      |
| Vistagen Therapeutics Inc    | Vistagen Therapeutics Inc    | CUSIP: 92840H400<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    250188 | NS      | $165599.44    | 0.90%             |  |  |  | No            |                  1 | On Loan: No      |
| QUANTUM BIOPHARMA            | QUANTUM BIOPHARMA            | CUSIP: 000000000<br>LEI: N/A                  | Long             | EC               | CORP              | CA        |     46617 | NS      | $0.00         | 0.00%             |  |  |  | No            |                  1 | On Loan: No      |
| Neuronetics Inc              | Neuronetics Inc              | CUSIP: 64131A105<br>LEI: 549300T0911ILTTG7P06 | Long             | EC               | CORP              | US        |    270916 | NS      | $373864.08    | 2.02%             |  |  |  | No            |                  1 | On Loan: —       |
| Relmada Therapeutics Inc     | Relmada Therapeutics Inc     | CUSIP: 75955J402<br>LEI: 549300217EASRZ9JSF81 | Long             | EC               | CORP              | US        |    319510 | NS      | $1543233.30   | 8.35%             |  |  |  | No            |                  1 | On Loan: No      |
| AbbVie Inc                   | AbbVie Inc                   | CUSIP: 00287Y109<br>LEI: FR5LCKFTG8054YNNRU85 | Long             | EC               | CORP              | US        |      2943 | NS      | $672446.07    | 3.64%             |  |  |  | No            |                  1 | On Loan: No      |
| Alkermes PLC                 | Alkermes PLC                 | CUSIP: 000000000<br>LEI: N/A                  | Long             | EC               | CORP              | IE        |     30580 | NS      | $855628.40    | 4.63%             |  |  |  | No            |                  1 | On Loan: No      |
| Neuphoria Therapeutics Inc   | Neuphoria Therapeutics Inc   | CUSIP: 64136E102<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    134194 | NS      | $520672.72    | 2.82%             |  |  |  | No            |                  1 | On Loan: —       |
| Atai Beckley NV              | Atai Beckley NV              | CUSIP: 000000000<br>LEI: 391200Z8UWPJSNBNCA11 | Long             | EC               | CORP              | NL        |    548603 | NS      | $2243786.27   | 12.14%            |  |  |  | No            |                  1 | On Loan: No      |
| Pasithea Therapeutics Corp   | Pasithea Therapeutics Corp   | CUSIP: 70261F202<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    304721 | NS      | $393090.09    | 2.13%             |  |  |  | No            |                  1 | On Loan: No      |
| Incannex Healthcare Inc      | Incannex Healthcare Inc      | CUSIP: 45333F109<br>LEI: N/A                  | Long             | EC               | CORP              | AU        |    663727 | NS      | $237614.27    | 1.29%             |  |  |  | No            |                  1 | On Loan: No      |
| Supernus Pharmaceuticals Inc | Supernus Pharmaceuticals Inc | CUSIP: 868459108<br>LEI: 549300GRM36VBKISYJ58 | Long             | EC               | CORP              | US        |     28394 | NS      | $1411181.80   | 7.64%             |  |  |  | No            |                  1 | On Loan: No      |
| BLACKROCK TREASURY TRUST     | BLACKROCK TREASURY TRUST     | CUSIP: 000000000<br>LEI: N/A                  | Long             | STIV             | RF                | US        |    755900 | NS      | $755900.42    | 4.09%             |  |  |  | No            |                  1 | On Loan: No      |
| SAGE THERAPEUTICS INC        | SAGE THERAPEUTICS INC        | CUSIP: 000000000<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     89780 | NS      | $0.00         | 0.00%             |  |  |  | No            |                  3 | On Loan: No      |
| UNBUZZD WELLNESS INC         | UNBUZZD WELLNESS INC         | CUSIP: 000000000<br>LEI: N/A                  | Long             | EC               | CORP              | CA        |    263236 | NS      | $0.00         | 0.00%             |  |  |  | No            |                  1 | On Loan: No      |
| Cybin Inc                    | Cybin Inc                    | CUSIP: 23256X407<br>LEI: 549300NTYWN4CVYSCN32 | Long             | EC               | CORP              | CA        |     98058 | NS      | $802114.44    | 4.34%             |  |  |  | No            |                  1 | On Loan: —       |
| Neurocrine Biosciences Inc   | Neurocrine Biosciences Inc   | CUSIP: 64125C109<br>LEI: 549300FECER0XBN49756 | Long             | EC               | CORP              | US        |      5901 | NS      | $836938.83    | 4.53%             |  |  |  | No            |                  1 | On Loan: No      |
| Bright Minds Biosciences Inc | Bright Minds Biosciences Inc | CUSIP: 10919W405<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      9944 | NS      | $776029.76    | 4.20%             |  |  |  | No            |                  1 | On Loan: No      |

### Signature

**Date Signed:** 2026-02-21

**Name of Applicant:** AdvisorShares Trust

**Signature:** Dan Ahrens

**Name of Signer:** Dan Ahrens

**Title:** Secretary and Treasurer